| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/27/2005 | WO2005007172A1 Glycoside-containing liposome |
| 01/27/2005 | WO2005007171A1 Accelerator for mineral absorption and use thereof |
| 01/27/2005 | WO2005007170A1 Method for treating irritable bowel syndrome using laxatives |
| 01/27/2005 | WO2005007169A2 Liposomes containing phosphate glycerol groups for treating acute inflammatory condition |
| 01/27/2005 | WO2005007168A1 A stable clozapine suspension formulation |
| 01/27/2005 | WO2005007167A1 Solid pharmaceutical preparation |
| 01/27/2005 | WO2005007166A1 Treatment of sexual dysfunction |
| 01/27/2005 | WO2005007165A1 Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 01/27/2005 | WO2005007163A1 Antipruritic agent containing chroman compound as active ingredient |
| 01/27/2005 | WO2005007162A1 Compounds augmenting the activity of antibacterial agents |
| 01/27/2005 | WO2005007161A1 Remedy for pruritus comprising piperidine derivative as the active ingredient |
| 01/27/2005 | WO2005007160A1 Enema preparation |
| 01/27/2005 | WO2005007159A1 Methods for treating vascular diseases |
| 01/27/2005 | WO2005007158A1 Treatment of patients with chronic lymphocytic leukemia |
| 01/27/2005 | WO2005007156A1 Compositions of a cyclooxygenase-2 selective inhibitor and an angiotensin ii receptor antagonist for the treatment of central nervous system damage |
| 01/27/2005 | WO2005007155A1 Medicinal composition |
| 01/27/2005 | WO2005007154A1 Preventive and/or therapeutic agent for pain |
| 01/27/2005 | WO2005007153A1 A composition of amino acid-iodine complex and methods for preparing and application |
| 01/27/2005 | WO2005007152A1 Treating cachexia and excessive catabolism with (-)-hydroxycitric acid |
| 01/27/2005 | WO2005007150A2 Method for inhibiting protein synthesis in sperm |
| 01/27/2005 | WO2005007149A1 Ambroxol for treating acute pains |
| 01/27/2005 | WO2005007148A1 Ambroxol for treating epilepsy |
| 01/27/2005 | WO2005007147A1 Ambroxol for treating tinnitus |
| 01/27/2005 | WO2005007146A1 Ambroxol for treating chronic nociceptive pains |
| 01/27/2005 | WO2005007145A1 Pharmaceutical product comprising a beta-2 adrenoceptor agonist and an antihistamine |
| 01/27/2005 | WO2005007144A2 Method of diagnosis and treatment for asthma based on haplotype association |
| 01/27/2005 | WO2005007143A2 Use of makrolides and ketolides for the treatment of tuberculosis |
| 01/27/2005 | WO2005007142A2 Liquid compositions comprising formoterol |
| 01/27/2005 | WO2005007141A2 Ubiquitin ligase inhibitors and methods related thereto |
| 01/27/2005 | WO2005007140A1 Pharmaceutical composition containing insect repellent |
| 01/27/2005 | WO2005007138A1 Pharmaceutical formulations |
| 01/27/2005 | WO2005007137A2 Tablets containing ambroxol |
| 01/27/2005 | WO2005007135A1 Pharmaceutical compositions |
| 01/27/2005 | WO2005007134A1 Powdery formulations for inhalation, containing a novel anticholinergic agent |
| 01/27/2005 | WO2005007132A1 Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
| 01/27/2005 | WO2005007131A2 Propofol formulations with non-reactive container closures |
| 01/27/2005 | WO2005007130A1 Stable pharmaceutical compositions containing an ace inhibitor |
| 01/27/2005 | WO2005007129A2 Topical formulations with bioactive components |
| 01/27/2005 | WO2005007124A2 Substituted dihydropyrimidine inhibitors of calcium channel function |
| 01/27/2005 | WO2005007122A2 Polymer stabilization |
| 01/27/2005 | WO2005007117A2 Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders |
| 01/27/2005 | WO2005007112A2 Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
| 01/27/2005 | WO2005007111A2 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 01/27/2005 | WO2005007110A2 Compositions and methods for hydrophobic drug delivery |
| 01/27/2005 | WO2005007107A2 Histamine and cck2/gastrin receptor blockade in the treatment of acid-peptic disease and cancer |
| 01/27/2005 | WO2005007106A2 Compositions of a cyclooxygenase-2 selective inhibitor and a non-nmda glutamate modulator for the treatment of central nervous system damage |
| 01/27/2005 | WO2005007103A2 Use of parthenolide derivatives as antileukemic and cytotoxic agents |
| 01/27/2005 | WO2005007102A2 Phytochemicals for the treatment of mastalgia, endometriosis and hpv-related conditions including cervical dysplasia |
| 01/27/2005 | WO2005007101A2 Compositions and methods for the enhanced uptake of therapeutic agents through the bladder epithelium |
| 01/27/2005 | WO2005007099A2 Pkb inhibitors as anti-tumor agents |
| 01/27/2005 | WO2005007098A2 Nucleic acid therapy to enhance cartilage repair |
| 01/27/2005 | WO2005007096A2 Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator |
| 01/27/2005 | WO2005007094A2 Asthma and allergic inflammation modulators |
| 01/27/2005 | WO2005007092A2 Novel chemical compounds |
| 01/27/2005 | WO2005007088A2 Stabilized anthocyanin extract from garcinia indica |
| 01/27/2005 | WO2005007085A2 Pyrazolo pyrimidine derivatives and methods of use thereof |
| 01/27/2005 | WO2005007084A2 Pancratistatin cyclic phosphate prodrugs an phenpanstatin cyclic phosphate prodrugs |
| 01/27/2005 | WO2005007083A2 Chemical compounds |
| 01/27/2005 | WO2005007082A2 Treatment of chronic bacterial infection |
| 01/27/2005 | WO2005007081A2 Compounds and methods for delivery of prostacyclin analogs |
| 01/27/2005 | WO2005007080A2 Methods and compositions for delivery of catecholic butanes for treatment of tumors |
| 01/27/2005 | WO2005007072A2 Methods and pharmaceutical compositions for healing wounds |
| 01/27/2005 | WO2005007070A2 Stable pharmaceutical composition |
| 01/27/2005 | WO2005007069A2 Soft gel formulations for saquinavir |
| 01/27/2005 | WO2005007068A1 Nicotine packaging system |
| 01/27/2005 | WO2005006899A1 Treatment of male sexual dysfunction |
| 01/27/2005 | WO2005006890A2 Foods, beverages, condiments, spices and salad dressings with specialized supplements |
| 01/27/2005 | WO2005006881A2 Salt taste modification |
| 01/27/2005 | WO2005006878A1 Compositions for improved oxidative status in companion animals |
| 01/27/2005 | WO2005006877A1 Compositions and methods for decreasing age-related deterioration in metal activities in companion animals |
| 01/27/2005 | WO2005006864A1 Genetic vaccines for cancer therapy |
| 01/27/2005 | WO2005006860A2 Azole derivatives and methods for making the same |
| 01/27/2005 | WO2004108941A8 Biologically active oils |
| 01/27/2005 | WO2004108673A3 Inhibitors of papilloma virus |
| 01/27/2005 | WO2004105775A8 Pharmaceutical composition comprising glucan derived from microalgae |
| 01/27/2005 | WO2004105728A3 Solid dispersions of cefpodoxime proxetil and processes for their preparation |
| 01/27/2005 | WO2004104005A3 Immunosuppressive effects of pteridine derivatives |
| 01/27/2005 | WO2004103960A3 Compounds and uses thereof |
| 01/27/2005 | WO2004101512A3 Naphthyridine integrase inhibitors |
| 01/27/2005 | WO2004100949A3 Solid-state forms of 5-(difluoromethoxy)-2-((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-1h-benzimidazole (pantoprazole) sodium aqua complexes |
| 01/27/2005 | WO2004100894A3 Drug formulations having reduced abuse potential |
| 01/27/2005 | WO2004099371A3 Methods of treating ischemic related conditions |
| 01/27/2005 | WO2004099130A3 1,2-diarylimidazoles useful as inhibitors of cox |
| 01/27/2005 | WO2004098579A3 Combination of a glycine/nmda antagonist and a tachykinin nk-1 receptor antagonist for use in the treatment of neurodegeneration |
| 01/27/2005 | WO2004098518A3 Pyrazole-amide compounds useful as kinase inhibitors |
| 01/27/2005 | WO2004096234A3 Kinase inhibitor phosphonate conjugates |
| 01/27/2005 | WO2004093884A3 High drug load mesalazine sachet |
| 01/27/2005 | WO2004092334A3 Methods of producing edible fungi containing activated folates and nutritional supplements containing activated folates |
| 01/27/2005 | WO2004091613A3 Substituted phenyl acetamides and their use as protease inhibitors |
| 01/27/2005 | WO2004091578A8 Novel encochleation methods, cochleates and methods of use |
| 01/27/2005 | WO2004091528A3 Delivery systems of homogeneous thermoreversible alginate films |
| 01/27/2005 | WO2004087654A3 Phospholipase c inhibitors for use in treating inflammatory disorders |
| 01/27/2005 | WO2004087120A3 Use of quinazoline derivatives with src kinase inhibitory activity for the treatment of hypertension |
| 01/27/2005 | WO2004087043B1 Stable ophthalmic formulation containing an antibiotic and a corticosteroid |
| 01/27/2005 | WO2004084927A3 Compositions for inducing of immunotolerance |
| 01/27/2005 | WO2004084861A3 Angiogenesis promotion by prostaglandin compositions and methods |
| 01/27/2005 | WO2004084829A3 Esterified fatty acid composition |
| 01/27/2005 | WO2004082686A3 Use of compounds with combined 5-ht1a and ssri activities to treat sexual dysfunction |
| 01/27/2005 | WO2004082606A3 Fused pyrrole compounds |
| 01/27/2005 | WO2004082580A3 Photostabilized topical formulations of ketoprofen containing two uv filters |